688176.SH
亚虹医药-U
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 11.49
−5.82%Margins
Gross margin
72.6%
EBITDA margin
-141.3%
EBIT margin
-158.5%
Net margin
-155.1%
FCF margin
-156.2%
-30.4%
Return on equity
-22.3%
Return on assets
-25.2%
Return on invested capital
0.14x
Asset turnover
-CNY 425.9M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026